Expression of Diverse Angiogenesis Factor in Different Stages of the 4T1 Tumor as a Mouse Model of Triple-Negative Breast Cancer

Saba Malekian ^1,2 , Marveh Rahmati ¹ , Soyar Sari ² , Monireh Kazemimanesh ³ , Raheleh Kheirbakhsh ¹ , Ahad Muhammadnejad ¹ , Saeid Amanpour ¹ *

Cited by CrossRef: 20

1- Ruyani S, Sumarsono S. Exposure to Valproic acid (VPA) resulted in alterations in the expression of angiogenic genes (NRP-1, VEGFA, VEGFR-2 and sFlt1) and histological modifications in the placenta of mice (Mus musculus). Reproductive Toxicology. 2023;119:108405 [Crossref]

2- Mondal J, Chakraborty K, Bunggulawa E, An J, Revuri V, Nurunnabi M, Lee Y. Recent advancements of hydrogels in immunotherapy: Breast cancer treatment. Journal of Controlled Release. 2024;372:1 [Crossref]

3- Fu Y, Wang N, Yang A, Xu Z, Zhang W, Liu H, Law H, Yan F. Ultrasensitive Detection of Ribonucleic Acid Biomarkers Using Portable Sensing Platforms Based on Organic Electrochemical Transistors. Anal Chem. 2021;93(43):14359 [Crossref]

4- Tanito K, Nii T, Wakuya K, Hamabe Y, Yoshimi T, Hosokawa T, Kishimura A, Mori T, Katayama Y. Inflammation-Triggering Engineered Macrophages (MacTriggers) Enhance Reactivity of Immune Checkpoint Inhibitor Only in Tumor Tissues. Cancers. 2024;16(22):3787 [Crossref]

5- Yu F, Shang X, Zhu Y, Lou H, Liu Y, Meng T, Hong Y, Yuan H, Hu F. Self-preparation system using glucose oxidase-inspired nitroreductase amplification for cascade-responsive drug release and multidrug resistance reversion. Biomaterials. 2021;275:120927 [Crossref]

6- Wang Y, Ding C, Zhao Y, Zhang J, Ding Q, Zhang S, Wang N, Yang J, Xi S, Zhao T, Zhao C, Liu W. Sodium alginate/poly(vinyl alcohol)/taxifolin nanofiber mat promoting diabetic wound healing by modulating the inflammatory response, angiogenesis, and skin flora. International Journal of Biological Macromolecules. 2023;252:126530 [Crossref]

7- Sader D, Zlotver I, Moya S, Calabrese G, Sosnik A. Doubly self-assembled dermatan sulfate/chitosan nanoparticles for targeted siRNA delivery in cancer therapy. Journal of Colloid and Interface Science. 2025;680:763 [Crossref]

8- Lai V, Neshat S, Rakoski A, Pitingolo J, Sabedra J, Li S, Shodhan A, Doloff J. Crystallization of the Multi-Receptor Tyrosine Kinase Inhibitor Sorafenib for Controlled Long-Term Drug Delivery Following a Single Injection. Cel Mol Bioeng. 2021;14(5):471 [Crossref]

9- Bhargava A, Popel A, Pathak A. Vascular phenotyping of the invasive front in breast cancer using a 3D angiogenesis atlas. Microvascular Research. 2023;149:104555 [Crossref]

10- Pournemati B, Tabesh H, Mehdinavaz Aghdam R, Rezayan A, Poorkhalil A, Ahmadi Tafti S, Heirani‐Tabasi A, Eyni H, Malekmohamadi M, Boroumand S, Pinna A. An Alginate/Gelatin Injectable Hydrogel Containing Au Nanoparticles for Transplantation of Embryonic Mouse Cardiomyocytes in Myocardial Repair. Macromolecular Bioscience. 2024; [Crossref]

11- Bencze N, Schvarcz C, Kriszta G, Danics L, Szőke É, Balogh P, Szállási Á, Hamar P, Helyes Z, Botz B. Desensitization of Capsaicin-Sensitive Afferents Accelerates Early Tumor Growth via Increased Vascular Leakage in a Murine Model of Triple Negative Breast Cancer. Front Oncol. 2021;11 [Crossref]

12- Shiau J, Wu C, Chang S, Pan M, Liu W, Ou-Yang F, Chen F, Hou M, Shih S, Luo C. FAK Regulates VEGFR2 Expression and Promotes Angiogenesis in Triple-Negative Breast Cancer. Biomedicines. 2021;9(12):1789 [Crossref]

13- Ramos J, Abdel‐Salam M, Nobre D, Glanzmann N, de Souza C, Leite E, de Abreu Teles P, Barbosa A, Barcelos L, dos Reis D, Cassali G, de Lima M, de Castro Q, Grabe‐Guimarães A, da Silva A, de Souza‐Fagundes E. Acute toxicity and antitumor potential of 1,3,4‐trisubstituted‐1,2,3‐triazole dhmtAc‐loaded liposomes on a triple‐negative breast cancer model. Archiv der Pharmazie. 2022;355(9) [Crossref]

14- Silveira Rabelo A, Mertens-Talcott S, Chew B, Noratto G. Dark Sweet Cherry (Prunus avium) Anthocyanins Suppressed ERK1/2-Akt/mTOR Cell Signaling and Oxidative Stress: Implications for TNBC Growth and Invasion. Molecules. 2022;27(21):7245 [Crossref]

15- Yang Q, Chen Z, Qiu Y, Huang W, Wang T, Song L, Sun X, Li C, Xu X, Kang L. Theranostic role of 89Zr- and 177Lu-labeled aflibercept in breast cancer. Eur J Nucl Med Mol Imaging. 2024;51(5):1246 [Crossref]

16- Xian S, Chen X, Ren S, Chen X, Wang H. Ionizable STING-Activating Nanoadjuvants Enhance Tumor Immunogenicity and Potentiate Immunotherapy Efficacy in Solid Tumors. 2024;84(18):3044 [Crossref]

17- Xu Y, Lv J, Shen N, Tang Z, Chen X. A self-activating nanoized vascular disrupting agent for selective anti-tumor therapy. Biomaterials. 2022;288:121736 [Crossref]

18- Jiang W, Han Y, Liang T, Zhang C, Gao F, Hou G. Down-Regulation of Toll-Like Receptor 5 (TLR5) Increased VEGFR Expression in Triple Negative Breast Cancer (TNBC) Based on Radionuclide Imaging. Front Oncol. 2021;11 [Crossref]

19- Chaudhari D, Katari O, Ghadi R, Kuche K, Date T, Bhargavi N, Jain S. Unfolding the Potency of Adenosine in Targeting Triple Negative Breast Cancer via Paclitaxel-Incorporated pH-Responsive Stealth Liposomes. ACS Biomater Sci Eng. 2022;8(8):3473 [Crossref]

20- Goangul M, Erenso D, Gao Y, Chen L, Eshun K, Alvarez G, Crogman H. Assessing Radiation Effects on Chemo-Treated BT20 and 4T1 Breast Cancer, and Neuroblastoma Cell Lines: A Study of Single and Multiple-Cell Ionization via Infrared Laser Trapping. Radiation. 2024;4(1):85 [Crossref]